JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer
- 8 November 2007
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 111 (3) , 439-448
Abstract
Expression of the JAG1 Notch ligand has previously been shown to correlate with poor overall survival in women with advanced breast cancer. We undertook to test whether expression of JAG1 is associated with reduced disease free survival (DFS) in 887 samples from a prospectively accrued LNN cohort with a median follow-up greater than 8 years. Moderate to high JAG1 mRNA expression was associated with reduced DFS in univariate analysis (hazard ratio of 1.58; 95% confidence interval, 1.03–2.40; P = 0.034) and correlated with large tumor size, ER and PgR negativity, high tumor grade, and p53 antibody reactivity. Although elevated risk of reduced DFS in patients with high JAG1 mRNA did not persist with adjustment for other prognostic factors, it did in combination with HER2. JAG1 mRNA was positively associated with expression of basal breast cancer markers, however, in contrast to the finding that basal gene expression is most strongly associated with reduced DFS in the first 36 months of follow-up, JAG1 mRNA expression was associated with reduced DFS through the full follow-up period. Also, tumors expressing high levels of both mRNA and protein showed reduced DFS as compared to all other groups in univariate analysis (hazard ratio of 1.73; 95% confidence interval, 1.09–2.74; P = 0.020). Thus, JAG1 expression is associated with poor DFS in LNN breast cancer. As JAG1 is a target of several oncogenic signaling pathways, and is a ligand for Notch, these data provide novel insights into signaling that may contribute to progression of early stage breast cancer.Keywords
This publication has 35 references indexed in Scilit:
- Expression of Notch pathway genes in mammalian epidermis and modulation by β‐CateninDevelopmental Dynamics, 2007
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importanceEuropean Journal of Cancer, 2006
- Concordance among Gene-Expression–Based Predictors for Breast CancerNew England Journal of Medicine, 2006
- Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signalingCancer Cell, 2005
- Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesisJournal of Cell Biology, 2004
- The Combination of p53 Mutation and neu/erbB-2 Amplification Is Associated With Poor Survival in Node-Negative Breast CancerJournal of Clinical Oncology, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathwaysOncogene, 2000